KDR peptides and vaccines comprising the same
AssigneeOncotherapy Science, Inc.
InventorsHideaki Tahara, Satoshi Wada, Takuya Tsunoda
Life of this patent
Estimating the term…
Abstract
The present invention provides nonapeptides selected from peptides comprising the amino acid sequence of SEQ ID NO:2, 3, 5, 8, 11, or 12; nonapeptides or decapeptides selected from peptides comprising the amino acid sequence of SEQ ID NO:29, 30, 33, 34, 40, or 46; and peptides with cytotoxic T cell inducibility, in which one, two, or several amino acids are substituted or added to the above-mentioned amino acid sequences, as well as pharmaceuticals for treating or preventing tumors, where the pharmaceuticals comprise these peptides. The peptides of this invention can be used as vaccines.
Claims13
A nonapeptide consisting of the amino acid sequence of SEQ ID NO:
- 29 or 33.
A peptide with cytotoxic T cell inducibility, wherein zero, one or two amino acids are substituted to the amino acid sequence of SEQ ID NO:
- 29 or 33, and the peptide binds to an HLA-A0201 restricted T cell receptor and induces a CTL response.
Dependencies are inferred from the claim text.